Theranos failed — here’s what’s really possible

Jurors are still deliberating in the trial of Elizabeth Holmes. The core of the trial focuses on whether or not Holmes defrauded investors by making unsubstantiated claims about her revolutionary Edison didn’t quite exist as it was promised. But other companies are paving the way in the diagnostics world that can do more with smaller volumes of blood. Here’s what’s really possible. Subscribe: Like The Verge on Facebook: Follow on Twitter: Follow on Instagram: Why’d You Push That Button Podcast: The Vergecast Podcast: More about our podcasts: Read More: Community guidelines: Wallpapers from The Verge: Subscribe to Verge Science on YouTube, a new home base for our explorations into the future of science: